If You Invested in International Flavors&Fragranc (IFF)

International Flavors & Fragrances Inc. (IFF) (NYSE: IFF) is described in its public communications as a global leader in flavors, fragrances, food ingredients, health and biosciences. The company focuses on creating what it calls “essential solutions for a better world,” combining science and creativity to develop scents, tastes, ingredients and sensorial experiences that are used in products across food, beverage, personal care, home care and related markets. IFF presents itself as an international collective of thinkers that partners with customers to bring forward scents, tastes, experiences, ingredients and solutions for products that consumers crave.

According to its own descriptions, IFF’s activities span several major domains: flavors and tastes for food and beverage applications; fragrances and scent ingredients; food ingredients; and health and biosciences. In various press releases, IFF notes that it operates through segments such as Taste, Health & Biosciences, Scent and Food Ingredients, which together form the core of its business. These segments are referenced in the company’s financial reporting and are used to describe how it analyzes its performance.

Business segments and activities

In its third quarter 2025 results release, IFF reports and comments on four primary segments:

• Taste – This segment is associated with flavors and related solutions for food and beverage customers. IFF reports sales and adjusted operating EBITDA for the Taste segment and discusses regional performance, pricing and cost discipline in this area.
• Health & Biosciences – IFF describes this segment as including activities in areas such as food biosciences, home and personal care and animal nutrition. The company highlights that performance in Health & Biosciences is influenced by demand in these categories and that it focuses on innovation and productivity gains within this segment.
• Scent – The Scent segment covers fine fragrances, consumer fragrances and fragrance ingredients. In its segment summary, IFF notes performance in fine fragrance, consumer fragrances and fragrance ingredients, and refers to specialties and commodities within fragrance ingredients.
• Food Ingredients – IFF reports Food Ingredients as a distinct segment, referencing categories such as inclusions and protein solutions in its financial commentary. The company discusses sales trends and margin improvement initiatives within this segment.

Beyond its segment reporting, IFF’s news releases describe specific operational initiatives. For example, the company has implemented an advanced industrial dosing system called the Colibri robot at its cross-category Scent and Taste production plant in Chin Bee, Singapore. This system is used to produce fragrance sample batches on demand and is intended to accelerate the path from ideation to formulation for fragrance creation, handling multiple ingredients simultaneously and significantly increasing automation and sample throughput.

IFF also highlights investments in sustainable manufacturing and energy use. At its Scent R&D and fragrance ingredients manufacturing plant in Benicarló, Spain, the company has installed a nature-based green hydrogen production facility in partnership with Iberdrola. According to IFF, this facility uses renewable electricity to produce hydrogen for hydrogenation reactions used in manufacturing key fragrance ingredients. The company states that this initiative supports its sustainability targets, including reductions in direct and indirect emissions, and is part of a broader effort to support operations for a sustainable future.

Geographic footprint and facilities

IFF’s public communications reference operations and investments in multiple regions. The company notes that it has a cross-category Scent and Taste production plant in Chin Bee, Singapore, where it has deployed the Colibri smart dosing robot. It also references other locations using this automation system, including Neuilly, France, and Hilversum, Netherlands. In Spain, IFF operates a Scent R&D and fragrance ingredients manufacturing plant in Benicarló, which is the site of its green hydrogen production facility.

In India, IFF has announced plans to build a new scent creative center in Mumbai, in the Powai neighborhood. The company states that this site is intended to serve as a creative center for fragrance innovation in India, housing more than 100 employees, with advanced labs, evaluation booths and a sensory evaluation space. IFF describes the Mumbai creative center as part of its long-term presence in India, where it notes it has been active in fragrance design for two decades.

Corporate governance and stock information

IFF’s SEC filings identify it as a corporation organized under the laws of New York, with its common stock listed on the New York Stock Exchange under the symbol IFF. The company files periodic and current reports with the U.S. Securities and Exchange Commission, including Forms 10-K, 10-Q and 8-K. Recent 8-K filings describe matters such as financial results, amendments to bylaws, changes in directors and certain officer appointments, as well as authorization of a share repurchase program.

The company’s board of directors and governance structure are discussed in several 8-K filings. For example, IFF has reported the appointment of new independent directors, including individuals with backgrounds in investment management, biotechnology, agribusiness and corporate strategy. The company has also disclosed amendments to its bylaws, including updates to committee nomenclature, revisions to indemnification provisions and the addition of a severability clause in the indemnification article.

Strategic collaborations and technology

In its public news releases, IFF describes collaborations and technology platforms that are relevant to its health and biosciences activities. One example is a strategic collaboration with BASF to accelerate the development of IFF’s Designed Enzymatic Biomaterials™ technology platform. The collaboration is aimed at creating next-generation enzyme technologies and biobased polymers for fabric, dish and personal care, as well as industrial cleaning applications. IFF states that this collaboration combines its expertise in biotechnology and protein engineering with BASF’s chemical capabilities.

IFF’s communications also emphasize the use of automation and advanced systems in its operations, such as the Colibri robot for fragrance sample dosing and the integration of green hydrogen production in manufacturing. These examples illustrate how the company applies technology and process innovation to support product development, sample creation and more sustainable production methods.

Financial reporting and segment performance

IFF’s third quarter 2025 earnings release, furnished as an exhibit to a Form 8-K, provides detail on how the company evaluates its performance by segment. The company reports sales and adjusted operating EBITDA for each of its segments—Taste, Health & Biosciences, Scent and Food Ingredients—and comments on factors such as regional demand, pricing, productivity gains and margin improvement initiatives. While specific figures are time-sensitive, the structure of this reporting and the identification of these four segments reflect how IFF organizes its business for financial and operational analysis.

The company also discusses the use of non-GAAP financial measures such as adjusted operating EBITDA and comparable currency neutral sales, and it provides cautionary statements regarding forward-looking information and risk factors. These disclosures are part of IFF’s regular financial communication practices as a public company.

Dividends, capital allocation and corporate actions

In a recent press release, IFF announced that its board of directors declared a regular quarterly cash dividend on its common stock. In another Form 8-K, the company disclosed that its board authorized a share repurchase program under which IFF may repurchase up to a specified dollar amount of its outstanding common stock. The filing explains that the program does not have a specified term or termination date and that repurchases may be made in various types of transactions, funded from available cash and cash provided by operating activities.

These actions, along with the company’s ongoing SEC reporting, reflect IFF’s status as a publicly traded issuer with an active approach to capital allocation, subject to the considerations and risk factors outlined in its filings.

Corporate purpose and positioning

Across multiple press releases, IFF consistently describes its purpose in terms of combining science, creativity and what it calls “heart” to develop solutions that advance wellness, delight the senses and enhance the human experience. The company refers to itself as an industry leader in food, beverage, health, biosciences and scent, and emphasizes its focus on sustainable innovations, sensorial experiences and collaboration with customers.

According to these communications, IFF’s work touches on products that are part of everyday life, from flavors and fragrances to ingredients and bioscience-based technologies. The company highlights sustainability initiatives, such as its green hydrogen project and biodegradable scent delivery systems, as part of its broader commitment to “Do More Good for people and planet,” a phrase it uses in its sustainability-related announcements.